Error: Could not add to watchlist. X

Morepen Laboratories Ltd

+ Watchlist
MORE:IN
Natl India
10.85
INR
0.55
4.82%
As of 06:17:29 ET on 06/03/2015.
Open
11.30
Day Range
10.85 - 11.44
Volume
1,025,943
Previous Close
11.40
52Wk Range
4.00 - 18.90
1 Yr Return
121.43%
Current P/E Ratio (TTM)
226.25
Earnings per Share (INR) (TTM)
0.05
Market Cap (b INR)
3.296
Shares Outstanding (m)
303.501
Price/Sales (TTM)
1.27
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Generic Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Morepen Laboratories Limited develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company's products are available in a variety of formulations, including tablets, capsules, injections, ointments, syrups, and powders. Morepen's products include Loratadine, Fluvastatin, Montelukast, and Fexofenadine.
ADDRESS
409 Antriksh Bhawan 4th Flr
22 Kasturba Gandhi Marg
New Delhi, 110 001
India
PHONE
91-11-2332-4443
  • Sushil Suri
    Chairman/Managing Director
  • Sanjay Sharma
    Executive Director
  • Ajay Kumar Sharma
    CFO/Gen Mgr:Finance & Accounts
  • Arun Kumar Sinha
    Dir:Technical
  • Thomas P Joshua
    Secretary/Compliance Officer
Show More